Baxter International Inc. (BAX) - Financial and Strategic SWOT Analysis Review

Date: April 7, 2015
Pages: 73
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B71F3E46D61EN
Leaflet:

Download PDF Leaflet

Baxter International Inc. (BAX) - Financial and Strategic SWOT Analysis Review
Baxter International Inc. (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief @Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
HIGHLIGHTS

Baxter International Inc. (Baxter) is a diversified global healthcare company. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It manufactures intravenous (IV) solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; IV nutrition products; infusion pumps; and inhalation anesthetics. It also offers recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The company operates in two divisions: BioScience and Medical Products. It has operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, the US.

The company seeks to maintain a leading position in the global healthcare market through acquisitions, partnerships and strategic alliances. In line with this strategy, Baxter acquired Chatham Therapeutics, LLC; Gambro AB; Synovis Life Technologies, Inc., Baxa Corporation, and Prism Pharmaceuticals, Inc.

Baxter International Inc. Key Recent Developments

Mar 30, 2015: Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving
Feb 23, 2015: Baxter Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters
Feb 17, 2015: Baxter Declares Quarterly Dividend
Jan 29, 2015: Baxter's Fourth Quarter Financial Results Exceed Expectations
Jan 20, 2015: Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Baxter International Inc. - Key Facts
Baxter International Inc. - Key Employees
Baxter International Inc. - Key Employee Biographies
Baxter International Inc. - Major Products and Services
Baxter International Inc. - Medical Equipment Pipeline Products Data
Baxter International Inc. Pipeline Products by Equipment Type
Baxter International Inc. Pipeline Products by Development Stage
Baxter International Inc. - History
Baxter International Inc. - Company Statement
Baxter International Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Baxter International Inc. - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Baxter International Inc. - Business Description
Business Description - BioScience
BioScience - Overview
BioScience - Financials
BioScience - Capital Expenditure
BioScience - Market View
Business Description - Medical Products
Medical Products - Overview
Medical Products - Financials
Medical Products - Capital Expenditure
Medical Products - Market View
Baxter International Inc. - Corporate Strategy
Baxter International Inc. - SWOT Analysis
SWOT Analysis - Overview
Baxter International Inc. - Strengths
Strength - Medical Products Franchise
Strength - Success in International Markets
Strength - Strong Research and Development Activities
Strength - Inorganic Growth
Baxter International Inc. - Weaknesses
Weakness - Patent Infringement Concerns
Weakness - Safety Issues: /Product Defects
Baxter International Inc. - Opportunities
Opportunity - Global Nephrology and Urology Devices Market
Opportunity - Strategic Restructuring
Opportunity - Product Approvals
Baxter International Inc. - Threats
Threat - Technological Changes
Threat - Substantial Debt
Threat - Competition
Threat - Risk of Infection
Baxter International Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Baxter International Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Baxter International Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Baxter International Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Baxter International Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
Baxter International Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 01, 2015: Baxter Completes CE Mark Approval for HOMECHOICE CLARIA Automated Peritoneal Dialysis System with SHARESOURCE
Mar 30, 2015: Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving
Feb 23, 2015: Baxter Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters
Feb 17, 2015: Baxter Declares Quarterly Dividend
Jan 29, 2015: Baxter's Fourth Quarter Financial Results Exceed Expectations
Jan 15, 2015: Palmetto Health in Columbia, South Carolina, Receives Prestigious $100, 000 Foster G. McGaw Prize for Excellence in Community Service
Dec 10, 2014: Baxter Announces Filing of Form 10 Registration Statement in Connection with Planned Spin Off of Biopharmaceuticals Business
Dec 09, 2014: Baxter's Culture of Community Engagement and Inclusion Recognized By Leading Organizations
Nov 11, 2014: Baxter Declares Quarterly Dividend
Oct 22, 2014: Baxter Initiates Voluntary Recall of Two Lots of INTRAVIA Containers in the U.S. and Canada

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Baxter International Inc., Key Facts
Baxter International Inc., Key Employees
Baxter International Inc., Key Employee Biographies
Baxter International Inc., Major Products and Services
Baxter International Inc. Number of Pipeline Products by Equipment Type
Baxter International Inc. Pipeline Products by Equipment Type
Baxter International Inc. Number of Pipeline Products by Development Stage
Baxter International Inc. Pipeline Products by Development Stage
Baxter International Inc., History
Baxter International Inc., Other Locations
Baxter International Inc., Subsidiaries
Baxter International Inc., Key Manufacturing Facilities
Baxter International Inc., Key Competitors
Baxter International Inc., Ratios based on current share price
Baxter International Inc., Annual Ratios
Baxter International Inc., Interim Ratios
Baxter International Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Baxter International Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Baxter International Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Baxter International Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
Baxter International Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Baxter International Inc. Pipeline Products by Equipment Type
Baxter International Inc. Pipeline Products by Development Stage
Baxter International Inc., Performance Chart (2010 - 2014)
Baxter International Inc., Ratio Charts
Baxter International Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Baxter International Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Baxter International Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Baxter International Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Baxter International Inc. (BAX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: